Health Condition 1: B741- Filariasis due to Brugia malayi
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients with Filarial Lymphoedema of the lower limbs (175 patients x 6 panchayaths) will be included in the study of which patients with lymphoedema stage III to VII according to the WHO Classification will be enrolled for the Compressive Decongestive Therapy (96 patients/ panchayath x 3 panchayaths)
Exclusion criteria
Exclusion criteria: Bedridden Patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Improved accessibility for lymphoedema management services through Community CDT Centres will result in improved quality of life for filariasis patients 2. Reduced number of ADL Attacks 3. Improved Quality of Life through customised footwearTimepoint: The primary outcome will be assessed at 3 months and 6 months from baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Amrita Institute of Medical Sciences